218 related articles for article (PubMed ID: 22188413)
1. The Munich-LTX-Score: predictor for survival after lung transplantation.
Huppmann P; Neurohr C; Leuschner S; Leuchte H; Baumgartner R; Zimmermann G; Meis T; von Wulffen W; Überfuhr P; Hatz R; Frey L; Behr J;
Clin Transplant; 2012; 26(1):173-83. PubMed ID: 22188413
[TBL] [Abstract][Full Text] [Related]
2. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
3. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
4. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
6. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
7. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
[TBL] [Abstract][Full Text] [Related]
8. Donor-recipient gender mismatch in lung transplantation: impact on obliterative bronchiolitis and survival.
Roberts DH; Wain JC; Chang Y; Ginns LC
J Heart Lung Transplant; 2004 Nov; 23(11):1252-9. PubMed ID: 15539123
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
[TBL] [Abstract][Full Text] [Related]
10. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
11. Factors indicative of long-term survival after lung transplantation: a review of 836 10-year survivors.
Weiss ES; Allen JG; Merlo CA; Conte JV; Shah AS
J Heart Lung Transplant; 2010 Mar; 29(3):240-6. PubMed ID: 19932034
[TBL] [Abstract][Full Text] [Related]
12. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
13. Circulating and intrapulmonary C-reactive protein: a predictor of bronchiolitis obliterans syndrome and pulmonary allograft outcome.
Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Scheers H; Van Raemdonck DE; Dupont LJ; Verleden GM
J Heart Lung Transplant; 2009 Aug; 28(8):799-807. PubMed ID: 19632576
[TBL] [Abstract][Full Text] [Related]
14. Redo lung transplantation: a North American-European experience.
Novick RJ; Kaye MP; Patterson GA; Andréassian B; Klepetko W; Menkis AH; McKenzie FN
J Heart Lung Transplant; 1993; 12(1 Pt 1):5-15; discussion 15-6. PubMed ID: 8382951
[TBL] [Abstract][Full Text] [Related]
15. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
Reichenspurner H; Girgis RE; Robbins RC; Yun KL; Nitschke M; Berry GJ; Morris RE; Theodore J; Reitz BA
Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
[TBL] [Abstract][Full Text] [Related]
16. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
[TBL] [Abstract][Full Text] [Related]
17. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
18. Innate immunity influences long-term outcomes after human lung transplant.
Palmer SM; Burch LH; Trindade AJ; Davis RD; Herczyk WF; Reinsmoen NL; Schwartz DA
Am J Respir Crit Care Med; 2005 Apr; 171(7):780-5. PubMed ID: 15640363
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
